Patent · US Active

Titration of tapentadol

US11344512B2 · kind B2 · utility

1Cited by

7References

3Claims

0Family size

Assignee

GRÜNENTHAL GMBH · DE

Inventors

Claudia Lange · Wiesloch, DE
Ferdinand ROMBOUT · Valkenburg, NL

Key dates

Filing date	Jun 12, 2019
Grant date	May 31, 2022
Priority date	—
Expiry date	Jun 12, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The use of tapentadol for the manufacture of a medicament comprising at least one administration unit A containing dose a of tapentadol and at least one administration unit B containing dose b of tapentadol, where dose a<dose b, for the treatment of pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.